Great Ormond Street Hospital has applied for a fresh hearing in the case of Charlie Gard following claims of “new evidence relating to potential care for his condition”.
It goes after seven medical experts suggested unpublished data indicated therapy could improve the 11 -month-old’s brain condition.
Previously, the High court said it was unlikely a US doctor offering to treat Charlie would be able to cure him.
GOSH said it would “explore” the data.
Charlie’s case will be heard by Mr Justice Francis on Monday at 14:00 BST, according to a High Court listing.
A hospital spokesman mentioned: “Two international hospitals and their researchers have communicated to us as late as the last 24 hours that they have fresh indication about their proposed experimental treatment.
“We belief, in common with Charlie’s parents, it is right to explore this evidence.
“Great Ormond Street Hospital is devoting the High Court the opportunity to objectively assess the claims of fresh evidence.
“It will be for the High Court to make its decision on the facts.
“Our view has not changed. We believe it is right to seek the High Court’s opinion in light of the claimed new evidence.
“Our priority has always been, and will always be, the best interests of Charlie Gard.”
Under a High Court ruling, GOSH is forbidden from permitting Charlie to be transferred for nucleoside therapy anywhere.
‘Tested on mice’
Seven clinicians and researchers, including the US doctor, signed a letter explaining that the treatment “wouldve been” experimental for Charlie’s particular condition.
They claim that “ideally” the therapy would firstly be tested on mice but state that, in Charlie’s case, there is no such thing as period for such a trial.
Charlie has mitochondrial depletion syndrome, a rare genetic condition which affects the cells responsible for energy production and respiration and has left him unable to move or exhale without a ventilator.
Doctors at GOSH have said he cannot see, hear, move, call or swallow and that his life subsistence should be switched off because there is no chance of his condition improving.
But they lost a legal duel with the hospital last month when magistrates at the European Court of Human Rights ruled farther therapy would “continue to cause Charlie significant harm” .~ ATAGEND
Signatories to the new letter include a neurologist and studies and research chap from Rome Children’s Hospital, a scientist from Cambridge University’s Mitochondrial Biology Unit and two researchers from Vall d’Hebron Institut de Recerca in Barcelona.
“In light of this new information, reconsideration of treatment for Charlie Gard is respectfully advocated, ” the group said.